Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1989;27(Suppl 1):119S–124S. doi: 10.1111/j.1365-2125.1989.tb03472.x

Response to vigabatrin in relation to seizure type

R Michelucci, C A Tassinari
PMCID: PMC1379690  PMID: 2667603

Abstract

1 The purpose of this study was to evaluate the efficacy of vigabatrin in relation to the seizure type.

2 A review of the literature concerning the efficacy of vigabatrin in clinical trials was performed.

3 To date, vigabatrin has been used in a small number of patients with generalized seizures: in this group no significant effect was noted.

4 Vigabatrin was also given to a large number of patients with complex partial seizures: in this group vigabatrin produced a greater than 50% decrease in seizure frequency in almost 50% of patients included.

5 This review provides evidence that vigabatrin is effective in the treatment of complex partial seizures: patients with only one seizure type, low seizure frequency and unifocal EEG abnormalities are particularly expected to respond.

6 This implies that patients with complex partial seizures do not constitute an homogeneous group and that various parameters should be considered in the evaluation of the response to treatment.

Keywords: vigabatrin, seizure type, generalized seizures, complex partial seizures

Full text

PDF
119S

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Browne T. R., Mattson R. H., Penry J. K., Smith D. B., Treiman D. M., Wilder B. J., Ben-Menachem E., Napoliello M. J., Sherry K. M., Szabo G. K. Vigabatrin for refractory complex partial seizures: multicenter single-blind study with long-term follow-up. Neurology. 1987 Feb;37(2):184–189. doi: 10.1212/wnl.37.2.184. [DOI] [PubMed] [Google Scholar]
  2. Gram L., Klosterskov P., Dam M. gamma-Vinyl GABA: a double-blind placebo-controlled trial in partial epilepsy. Ann Neurol. 1985 Mar;17(3):262–266. doi: 10.1002/ana.410170307. [DOI] [PubMed] [Google Scholar]
  3. Gram L., Lyon B. B., Dam M. Gamma-vinyl-GABA: a single-blind trial in patients with epilepsy. Acta Neurol Scand. 1983 Jul;68(1):34–39. doi: 10.1111/j.1600-0404.1983.tb04812.x. [DOI] [PubMed] [Google Scholar]
  4. Holowach J., Thurston D. L., O'Leary J. Prognosis in childhood epilepsy. Follow-up study of 148 cases in which therapy had been suspended after prolonged anticonvulsant control. N Engl J Med. 1972 Jan 27;286(4):169–174. doi: 10.1056/NEJM197201272860401. [DOI] [PubMed] [Google Scholar]
  5. Lindsay J., Ounsted C., Richards P. Long-term outcome in children with temporal lobe seizures. I: Social outcome and childhood factors. Dev Med Child Neurol. 1979 Jun;21(3):285–298. doi: 10.1111/j.1469-8749.1979.tb01621.x. [DOI] [PubMed] [Google Scholar]
  6. Loiseau P., Hardenberg J. P., Pestre M., Guyot M., Schechter P. J., Tell G. P. Double-blind, placebo-controlled study of vigabatrin (gamma-vinyl GABA) in drug-resistant epilepsy. Epilepsia. 1986 Mar-Apr;27(2):115–120. doi: 10.1111/j.1528-1157.1986.tb03512.x. [DOI] [PubMed] [Google Scholar]
  7. Pazzaglia P., D'Alessandro R., Lozito A., Lugaresi E. Classification of partial epilepsies according to the symptomatology of seizures: practical value and prognostic implications. Epilepsia. 1982 Jun;23(3):343–350. doi: 10.1111/j.1528-1157.1982.tb06200.x. [DOI] [PubMed] [Google Scholar]
  8. Pedersen S. A., Klosterskov P., Gram L., Dam M. Long-term study of gamma-vinyl GABA in the treatment of epilepsy. Acta Neurol Scand. 1985 Sep;72(3):295–298. doi: 10.1111/j.1600-0404.1985.tb00873.x. [DOI] [PubMed] [Google Scholar]
  9. Rimmer E. M., Richens A. Double-blind study of gamma-vinyl GABA in patients with refractory epilepsy. Lancet. 1984 Jan 28;1(8370):189–190. doi: 10.1016/s0140-6736(84)92112-3. [DOI] [PubMed] [Google Scholar]
  10. Roger J., Dravet C., Menendez P., Bureau M. Les epilepsies partielles de l'enfant--evolution et facteurs de pronostic. Rev Electroencephalogr Neurophysiol Clin. 1981 Dec;11(3-4):431–437. doi: 10.1016/s0370-4475(81)80082-2. [DOI] [PubMed] [Google Scholar]
  11. Schechter P. J., Hanke N. F., Grove J., Huebert N., Sjoerdsma A. Biochemical and clinical effects of gamma-vinyl GABA in patients with epilepsy. Neurology. 1984 Feb;34(2):182–186. doi: 10.1212/wnl.34.2.182. [DOI] [PubMed] [Google Scholar]
  12. Tartara A., Manni R., Galimberti C. A., Hardenberg J., Orwin J., Perucca E. Vigabatrin in the treatment of epilepsy: a double-blind, placebo-controlled study. Epilepsia. 1986 Nov-Dec;27(6):717–723. doi: 10.1111/j.1528-1157.1986.tb03600.x. [DOI] [PubMed] [Google Scholar]
  13. Tassinari C. A., Michelucci R., Ambrosetto G., Salvi F. Double-blind study of vigabatrin in the treatment of drug-resistant epilepsy. Arch Neurol. 1987 Sep;44(9):907–910. doi: 10.1001/archneur.1987.00520210009010. [DOI] [PubMed] [Google Scholar]
  14. Tassinari C. A., Roger J. Prognosis and therapy of complex partial seizures with barbiturates, hydantoins, and other drugs. Adv Neurol. 1975;11:201–219. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES